|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018270,
umls-concept:C0034802,
umls-concept:C0079411,
umls-concept:C0205267,
umls-concept:C0308269,
umls-concept:C0334227,
umls-concept:C0376358,
umls-concept:C0392747,
umls-concept:C0443172,
umls-concept:C0597360,
umls-concept:C1515985,
umls-concept:C1706701
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-4-5
|
|
pubmed:abstractText |
Intermittent androgen ablation is a palliative treatment option for advanced prostate cancer which is associated with less side effects, improved quality of life of patients, and reduced costs. Regulation of growth and survival of prostate cancer cells during intermittent androgen withdrawal has not been studied in appropriate models yet.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2004 Wileey-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
401-8
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15065088-Androgen Antagonists,
pubmed-meshheading:15065088-Blotting, Western,
pubmed-meshheading:15065088-Cell Cycle,
pubmed-meshheading:15065088-Cell Division,
pubmed-meshheading:15065088-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15065088-Flow Cytometry,
pubmed-meshheading:15065088-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15065088-Humans,
pubmed-meshheading:15065088-Male,
pubmed-meshheading:15065088-Prostatic Neoplasms,
pubmed-meshheading:15065088-RNA, Messenger,
pubmed-meshheading:15065088-Receptor, Epidermal Growth Factor,
pubmed-meshheading:15065088-Tumor Cells, Cultured
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.
|
|
pubmed:affiliation |
Department of Urology, University of Innsbruck, Innsbruck, Austria.
|
|
pubmed:publicationType |
Journal Article
|
